<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский вестник Юга России</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Herald of the South of Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2219-8075-2023-14-4-35-43</article-id><article-id custom-type="elpub" pub-id-type="custom">mvjr-1803</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АЛЛЕРГОЛОГИЯ И ИММУНОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ALLERGOLOGY AND IMMUNOLOGY</subject></subj-group></article-categories><title-group><article-title>Особенности клинической картины и течения дефицита GATA2, осложнённого генерализованным веррукозом с исходом в миелодиспластический синдром во взрослом возрасте</article-title><trans-title-group xml:lang="en"><trans-title>Features of the clinical picture and course of GATA2 deficiency complicated by generalized verrucosis with an outcome in myelodysplastic syndrome in adulthood</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0800-5960</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фролов</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Frolov</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Евгений Александрович Фролов – врач аллерголог-иммунолог, младший научный сотрудник отделения Иммунопатологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Evgeny A. Frolov – allergist-immunologist, Junior Researcher at the Immunopathology department</p><p>Moscow</p></bio><email xlink:type="simple">frolovevgeny@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-1842-6521</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абдулаева</surname><given-names>Ф. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Abdulaeva</surname><given-names>F. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фатима Ильясовна Абдулаева – врач-ординатор</p><p>Москва</p></bio><bio xml:lang="en"><p>Fatima I. Abdulaeva – Resident Physician</p><p>Moscow</p></bio><email xlink:type="simple">fati_abd@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горностаева</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gornostaeva</surname><given-names>U. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Юлия Алексеевна Горностаева – к.м.н., старший научный сотрудник отделения Иммунопатологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Yulia A. Gornostaeva – Cand. Sci. (Med.), Senior Researcher at the Immunopathology department</p><p>Moscow</p></bio><email xlink:type="simple">ya.gornostaeva@nrcii.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1508-0640</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Латышева</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Latysheva</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Татьяна Васильевна Латышева – д.м.н., проф., профессор кафедры клинической аллергологии и иммунологии; заведующий отделения интенсивной терапии</p><p>Москва</p></bio><bio xml:lang="en"><p>Tatiana V. Latysheva – Professor, Dr. Sci. (Med.), Professor of the department of Clinical Allergology and Immunology; head of the Intensive Care Unit</p><p>Moscow</p></bio><email xlink:type="simple">tvlat@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1606-205X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Латышева</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Latysheva</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елена Александровна Латышева – д.м.н., доцент кафедры Клинической иммунологии факультета; заведующий отделения Иммунопатологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Elena A. Latysheva – Dr. Sci. (Med.), Associate Professor of the Department of Clinical Immunology; Head of the Immunopathology Department</p><p>Moscow</p></bio><email xlink:type="simple">ealat@mail.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7139-4882</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аминова</surname><given-names>Г. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Aminova</surname><given-names>G. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гулюмхан Эльвировна Аминова – врач-рентгенолог, заведующий отделением лучевой диагностики</p><p>Москва</p></bio><bio xml:lang="en"><p>Gulyumkhan E. Aminova – radiologist, head of the radiologydepartment</p><p>Moscow</p></bio><email xlink:type="simple">79263037827@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Государственный научный центр «Институт иммунологии» Федерального медико-биологического агентства</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Research Center – Institute of Immunology Federal Medical-Biological Agency</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Российский национальный исследовательский медицинский университет им. Н.И. Пирогова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Государственный научный центр «Институт иммунологии» Федерального медико-биологического агентства; Московский государственный медико-стоматологический университет имени А.И. Евдокимова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Research Center – Institute of Immunology Federal Medical-Biological Agency; A.I. Yevdokimov Moscow State University of Medicine and Dentistry</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Государственный научный центр «Институт иммунологии» Федерального медико-биологического агентства; Российский национальный исследовательский медицинский университет им. Н.И. Пирогова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Research Center – Institute of Immunology Federal Medical-Biological Agency; Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>26</day><month>11</month><year>2023</year></pub-date><volume>14</volume><issue>4</issue><fpage>35</fpage><lpage>43</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Фролов Е.А., Абдулаева Ф.И., Горностаева Ю.А., Латышева Т.В., Латышева Е.А., Аминова Г.Э., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Фролов Е.А., Абдулаева Ф.И., Горностаева Ю.А., Латышева Т.В., Латышева Е.А., Аминова Г.Э.</copyright-holder><copyright-holder xml:lang="en">Frolov E.A., Abdulaeva F.I., Gornostaeva U.A., Latysheva T.V., Latysheva E.A., Aminova G.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/1803">https://www.medicalherald.ru/jour/article/view/1803</self-uri><abstract><p>Дефицит GATA2 – редкое заболевание, относящееся к группе врождённых дефектов фагоцитов, которое клинически проявляется четырьмя синдромами: синдромом MonoMAC (миедисплазия и иммунодефицит, ассоциированный с развитием инфекций, вызванных Mycobacterium avium complex), синдромом дефицита моноцитов, дендритных клеток, В- и NK-лимфоцитов, синдромом Эмбергера, включающим первичную лимфедему с миелодисплазией и нейросенсорную потерю слуха, а также семейным миелодиспластическим синдромом и острым миелоидным лейкозом. Заболевание наследуется по аутосомно-доминантному типу, но в большинстве случаев мутации зародышевой линии гена GATA2 возникают de novo. Первые проявления заболевания встречаются в раннем взрослом возрасте, течение дефицита GATA2 является вариабельным и может различаться у лиц в одной семье, имеющих схожие генетические варианты. В статье представлен клинический случай манифестации дефицита GATA2 в возрасте семи лет в виде развития генерализованного веррукоза, лимфостаза нижней конечности, генерализованного туберкулёза с поражением брюшной полости, малого таза, органов грудной клетки. В результате обследования выявлен дефицит моноцитов, В- и NK-лимфоцитов, миелодиспластический синдром с мультилинейной дисплазией. Представлено подробное описание клинической картины и особенностей течения первичного иммунодефицитного состояния, результаты проведенного обследования и лечения.</p></abstract><trans-abstract xml:lang="en"><p>GATA2 deficiency is a rare disease belonging to the group of phagocyte birth defects, which is clinically manifested by four syndromes: MonoMac syndrome (myedysplasia and immunodeficiency associated with the development of infections caused by Mycobacterium avium complex); monocyte, dendritic cell, B- and NK-lymphocyte deficiency syndrome; Emberger syndrome, including primary lymphedema with myelodysplasia and sensorineural hearing loss, as well as familial myelodysplastic syndrome and acute myeloid leukemia. The disease is inherited by autosomal dominant type, but in most cases, mutations ofthe germ line of the GATA2 gene occur de novo. The first manifestations of the disease occur in early adulthood, the course of GATA2 deficiency is variable and may differ in individuals in the same family with similar genetic variants. The article presents a clinical case of manifestation of GATA2 deficiency at the age of seven years in the form of development of generalized verrucosis, lymphostasis of the lower limb, generalized tuberculosis with involvement of the abdominal cavity, small pelvis, and chest organs. The examination revealed deficiency of monocytes, B- and NK-lymphocytes, myelodysplastic syndrome with multilineage dysplasia. We present a detailed description of the clinical picture and peculiarities of the course of the primary immunodeficiency state, the results of the examination and treatment.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>первичный иммунодефицит</kwd><kwd>генерализованный веррукоз</kwd><kwd>миелодиспластический синдром</kwd><kwd>трансплантация гемопоэтических стволовых клеток</kwd></kwd-group><kwd-group xml:lang="en"><kwd>primary immunodeficiency</kwd><kwd>generalized verrucosis</kwd><kwd>myelodysplastic syndrome</kwd><kwd>hematopoietic stem cell transplantation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, et al. The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity. J Clin Immunol. 2022;42(7):1508-1520. https://doi.org/10.1007/s10875-022-01352-z</mixed-citation><mixed-citation xml:lang="en">Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, et al. The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity. J Clin Immunol. 2022;42(7):1508-1520. https://doi.org/10.1007/s10875-022-01352-z</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Сизякина Л.П., Андреева И.И. Справочник по клинической иммунологии. Ростов-на-Дону: Феникс; 2005.</mixed-citation><mixed-citation xml:lang="en">Sizyakina L.P., Andreeva I.I. Spravochnik po klinicheskoj immunologii. Rosotov-on-Don: Feniks; 2005. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Кондратенко И.В., Бологов А.А. Первичные иммунодефициты: учебное пособие. Москва: ИндексМед Медиа; 2020.</mixed-citation><mixed-citation xml:lang="en">Kondratenko I.V., Bologov A.A. Pervichnye immunodeficity: uchebnoe posobie. Moskva: IndeksMed Media; 2020. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Vinh DC, Patel SY, Uzel G, Anderson VL, Freeman AF, et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood. 2010;115(8):1519-29. https://doi.org/10.1182/blood-2009-03-208629</mixed-citation><mixed-citation xml:lang="en">Vinh DC, Patel SY, Uzel G, Anderson VL, Freeman AF, et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood. 2010;115(8):1519-29. https://doi.org/10.1182/blood-2009-03-208629</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bigley V, Haniffa M, Doulatov S, Wang XN, Dickinson R, et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med. 2011;208(2):227-34. https://doi.org/10.1084/jem.20101459</mixed-citation><mixed-citation xml:lang="en">Bigley V, Haniffa M, Doulatov S, Wang XN, Dickinson R, et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med. 2011;208(2):227-34. https://doi.org/10.1084/jem.20101459</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mansour S, Connell F, Steward C, Ostergaard P, Brice G, et al. Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases. Am J Med Genet A. 2010;152A(9):2287-96. https://doi.org/10.1002/ajmg.a.33445</mixed-citation><mixed-citation xml:lang="en">Mansour S, Connell F, Steward C, Ostergaard P, Brice G, et al. Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases. Am J Med Genet A. 2010;152A(9):2287-96. https://doi.org/10.1002/ajmg.a.33445</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43(10):1012-7. https://doi.org/10.1038/ng.913</mixed-citation><mixed-citation xml:lang="en">Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43(10):1012-7. https://doi.org/10.1038/ng.913</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653-5. https://doi.org/10.1182/blood-2011-05-356352</mixed-citation><mixed-citation xml:lang="en">Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653-5. https://doi.org/10.1182/blood-2011-05-356352</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Rodrigues NP, Tipping AJ, Wang Z, Enver T. GATA-2 mediated regulation of normal hematopoietic stem/progenitor cell function, myelodysplasia and myeloid leukemia. Int J Biochem Cell Biol. 2012;44(3):457-60. https://doi.org/10.1016/j.biocel.2011.12.004</mixed-citation><mixed-citation xml:lang="en">Rodrigues NP, Tipping AJ, Wang Z, Enver T. GATA-2 mediated regulation of normal hematopoietic stem/progenitor cell function, myelodysplasia and myeloid leukemia. Int J Biochem Cell Biol. 2012;44(3):457-60. https://doi.org/10.1016/j.biocel.2011.12.004</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y, Qi X, Liu B, Huang H. The STAT5-GATA2 pathway is critical in basophil and mast cell differentiation and maintenance. J Immunol. 2015;194(9):4328-38. https://doi.org/10.4049/jimmunol.1500018</mixed-citation><mixed-citation xml:lang="en">Li Y, Qi X, Liu B, Huang H. The STAT5-GATA2 pathway is critical in basophil and mast cell differentiation and maintenance. J Immunol. 2015;194(9):4328-38. https://doi.org/10.4049/jimmunol.1500018</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Homan CC, Venugopal P, Arts P, Shahrin NH, Feurstein S, et al. GATA2 deficiency syndrome: A decade of discovery. Hum Mutat. 2021;42(11):1399-1421. https://doi.org/10.1002/humu.24271</mixed-citation><mixed-citation xml:lang="en">Homan CC, Venugopal P, Arts P, Shahrin NH, Feurstein S, et al. GATA2 deficiency syndrome: A decade of discovery. Hum Mutat. 2021;42(11):1399-1421. https://doi.org/10.1002/humu.24271</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kozyra EJ, Pastor VB, Lefkopoulos S, Sahoo SS, Busch H, et al. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency. Leukemia. 2020;34(10):2673-2687. https://doi.org/10.1038/s41375-020-0899-5</mixed-citation><mixed-citation xml:lang="en">Kozyra EJ, Pastor VB, Lefkopoulos S, Sahoo SS, Busch H, et al. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency. Leukemia. 2020;34(10):2673-2687. https://doi.org/10.1038/s41375-020-0899-5</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Oleaga-Quintas C, de Oliveira-Júnior EB, Rosain J, Rapaport F, Deswarte C, et al. Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance. J Clin Immunol. 2021;41(3):639-657. https://doi.org/10.1007/s10875-020-00930-3</mixed-citation><mixed-citation xml:lang="en">Oleaga-Quintas C, de Oliveira-Júnior EB, Rosain J, Rapaport F, Deswarte C, et al. Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance. J Clin Immunol. 2021;41(3):639-657. https://doi.org/10.1007/s10875-020-00930-3</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123(6):809-21. https://doi.org/10.1182/blood-2013-07-515528</mixed-citation><mixed-citation xml:lang="en">Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123(6):809-21. https://doi.org/10.1182/blood-2013-07-515528</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Donadieu J, Lamant M, Fieschi C, de Fontbrune FS, Caye A, et al. Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients. Haematologica. 2018;103(8):1278-1287. https://doi.org/10.3324/haematol.2017.181909</mixed-citation><mixed-citation xml:lang="en">Donadieu J, Lamant M, Fieschi C, de Fontbrune FS, Caye A, et al. Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients. Haematologica. 2018;103(8):1278-1287. https://doi.org/10.3324/haematol.2017.181909</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Mardahl M, Jørgensen SE, Schneider A, Raaschou-Jensen K, Holm M, et al. Impaired immune responses to herpesviruses and microbial ligands in patients with MonoMAC. Br J Haematol. 2019;186(3):471-476. https://doi.org/10.1111/bjh.15947</mixed-citation><mixed-citation xml:lang="en">Mardahl M, Jørgensen SE, Schneider A, Raaschou-Jensen K, Holm M, et al. Impaired immune responses to herpesviruses and microbial ligands in patients with MonoMAC. Br J Haematol. 2019;186(3):471-476. https://doi.org/10.1111/bjh.15947</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Haugas M, Lilleväli K, Hakanen J, Salminen M. Gata2 is required for the development of inner ear semicircular ducts and the surrounding perilymphatic space. Dev Dyn. 2010;239(9):2452-69. https://doi.org/10.1002/dvdy.22373</mixed-citation><mixed-citation xml:lang="en">Haugas M, Lilleväli K, Hakanen J, Salminen M. Gata2 is required for the development of inner ear semicircular ducts and the surrounding perilymphatic space. Dev Dyn. 2010;239(9):2452-69. https://doi.org/10.1002/dvdy.22373</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Parta M, Shah NN, Baird K, Rafei H, Calvo KR, et al. Allogeneic Hematopoietic Stem Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen. Biol Blood Marrow Transplant. 2018;24(6):1250-1259. https://doi.org/10.1016/j.bbmt.2018.01.030</mixed-citation><mixed-citation xml:lang="en">Parta M, Shah NN, Baird K, Rafei H, Calvo KR, et al. Allogeneic Hematopoietic Stem Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen. Biol Blood Marrow Transplant. 2018;24(6):1250-1259. https://doi.org/10.1016/j.bbmt.2018.01.030</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Grossman J, Cuellar-Rodriguez J, Gea-Banacloche J, Zerbe C, Calvo K, et al. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Biol Blood Marrow Transplant. 2014;20(12):1940-8. https://doi.org/10.1016/j.bbmt.2014.08.004</mixed-citation><mixed-citation xml:lang="en">Grossman J, Cuellar-Rodriguez J, Gea-Banacloche J, Zerbe C, Calvo K, et al. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Biol Blood Marrow Transplant. 2014;20(12):1940-8. https://doi.org/10.1016/j.bbmt.2014.08.004</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Marciano BE, Olivier KN, Folio LR, Zerbe CS, Hsu AP, et al. Pulmonary Manifestations of GATA2 Deficiency. Chest. 2021;160(4):1350-1359. https://doi.org/10.1016/j.chest.2021.05.046</mixed-citation><mixed-citation xml:lang="en">Marciano BE, Olivier KN, Folio LR, Zerbe CS, Hsu AP, et al. Pulmonary Manifestations of GATA2 Deficiency. Chest. 2021;160(4):1350-1359. https://doi.org/10.1016/j.chest.2021.05.046</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">W est ES, Kingsbery MY, Mintz EM, Hsu AP, Holland SM, et al. Generalized verrucosis in a patient with GATA2 deficiency. Br J Dermatol. 2014;170(5):1182-6. https://doi.org/10.1111/bjd.12794</mixed-citation><mixed-citation xml:lang="en">W est ES, Kingsbery MY, Mintz EM, Hsu AP, Holland SM, et al. Generalized verrucosis in a patient with GATA2 deficiency. Br J Dermatol. 2014;170(5):1182-6. https://doi.org/10.1111/bjd.12794</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Rivera A, Tyring SK. Therapy of cutaneous human Papillomavirus infections. Dermatol Ther. 2004;17(6):441-8. https://doi.org/10.1111/j.1396-0296.2004.04047.x</mixed-citation><mixed-citation xml:lang="en">Rivera A, Tyring SK. Therapy of cutaneous human Papillomavirus infections. Dermatol Ther. 2004;17(6):441-8. https://doi.org/10.1111/j.1396-0296.2004.04047.x</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Bogaert DJ, Laureys G, Naesens L, Mazure D, De Bruyne M, et al. GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner. Br J Haematol. 2020;188(5):768-773. https://doi.org/10.1111/bjh.16247</mixed-citation><mixed-citation xml:lang="en">Bogaert DJ, Laureys G, Naesens L, Mazure D, De Bruyne M, et al. GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner. Br J Haematol. 2020;188(5):768-773. https://doi.org/10.1111/bjh.16247</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
